Form 4: Oscar Health COO Steven Wolin Reports Stock Sales and Option Exercises
SEC Form 4
Steven Wolin, Chief Operating Officer of Oscar Health, Inc., reported the exercise of stock options and subsequent sale of Class A Common Stock to cover tax obligations.
Summary
- On September 4, 2024, Steven Wolin, the Chief Operating Officer of Oscar Health, Inc., filed a Form 4 detailing changes in his beneficial ownership of the company's stock.
- Wolin exercised restricted stock units, which converted into Class A Common Stock.
- He then sold a portion of the acquired shares to satisfy tax withholding obligations.
- The sales occurred on September 3 and 4, 2024, at weighted average prices of $17.99, $17.46, and $17.85 per share.
- The total number of shares sold was 19,579.
- Following these transactions, Wolin directly owns 83,714 shares of Class A Common Stock and derivative securities representing rights to acquire additional shares.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing primarily reflects routine stock option exercises and sales for tax purposes, executed under a pre-arranged plan.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors to gauge management's sentiment and confidence in the company's prospects.
Stakeholder Impact
- The stock sales by a key executive could be perceived negatively by some shareholders, although the pre-arranged nature of the sales mitigates this concern.
Key Dates
| Date | Description |
|---|---|
| 2022-06-01 | Restricted stock units vest over a three-year period in 12 equal quarterly installments beginning June 1, 2022. |
| 2023-02-27 | Date prior to which the Rule 10b5-1 instruction letter was entered into. |
| 2023-06-01 | Restricted stock units vest over a three-year period in 12 equal quarterly installments beginning June 1, 2023. |
| 2024-06-01 | Restricted stock units vest over a three-year period in 12 equal quarterly installments beginning June 1, 2024. |
| 2024-09-01 | Date of restricted stock unit exercises. |
| 2024-09-03 | Date of stock sale at $17.99. |
| 2024-09-04 | Date of stock sales at $17.46 and $17.85. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.